{"task_id": "dab0c5963310253e", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 353/464)", "text": "is), CBCD, ALT, AST, ALP, bili\n344\nHyperthyroidism\n\n--- Page 366 ---\nINVESTIGATIONS (CONT\u2019D)\nSPECIAL\n\u0002\nTHYROID SCAN\ndiffuse homogeneous increased\niodine uptake suggests Graves\u2019 disease, multi\nfocal uptake suggests toxic multinodular goiter,\nincreased single focus suggests toxic adenoma,\nwhile decreased global uptake suggests thyroi\nditis or factitious hyperthyroidism\n\u0002\nRADIOACTIVE IODINE UPTAKE\nnormal 2 h uptake\n= 6 10%; <1% suggests thyroiditis, 1 6% sug\ngests iodine exposure, >10% suggests Graves\u2019,\ntoxic nodule, or toxic multinodular goiter\nDIAGNOSTIC ISSUES\nTHYROID HORMONE LEVELS AND INTERPRET\nATION\nTSH\nfT4\nfT3\nSubclinical hyperthyroidism\n#\nN\nN\nPrimary hyperthyroidism\n#\n\"\n\"\nT3 thyrotoxicosis\n#\nN\n\"\nSecondary hyperthyroidism\n\"/N\n\"\n\"\nMANAGEMENT\nTHYROID STORM\nABC, O2, IV. Propylthiouracil\n1000 mg PO/NG stat, then 300 mg PO q6h. Iodide\ndrops 2 3 PO q6h to be given 1 h after each dose of\nPTU. Dexamethasone 2 mg IV q6h, propranolol\n20 mg PO q6h. Cooling blankets\nTREAT UNDERLYING CAUSE\n\u0002\nANTITHYROID\nDRUGS\ninhibit\nthyroid\nhormone\nsynthesis; for Graves\u2019, multinodular goiter and\ntoxic adenoma only. Methimazole 20 40 mg PO\ndiv BID, propylthiouracil 300 600 mg PO div BID\nTID (PTU is no longer first line agent for hyperthyr\noidism due to potentially fatal hepatotoxicity)\n\u0002\nSODIUM IODATE\npotent inhibitor of peripheral T4\nconversion and decreases thyroid hormone release\nMANAGEMENT (CONT\u2019D)\n\u0002 b-BLOCKERS\n# tissue response to catecholamines\nand # peripheralconversionof T4 toT3;useasadjunct\n\u0002\nSTEROIDS\n# immune response and # peripheral\nconversion of T4 to T3; for severe hyperthyroidism\n\u0002\nRADIOIODINE I131 ABLATION\nfor Graves\u2019, multinod\nular goiter and toxic adenoma. Only give once the\nthyroid levels have been stabilized. Must discon\ntinue antithyroid drugs 3 7 days in advance. With\nhold if severe ophthalmopathy, smoking, or severe\nthyrotoxicosis as may make eye disease worse or\nlead to thyroid storm. Hypothyroidism within 2\nmonths is to be expected. Patients will require\nthyroid hormone replacement at 1.6 mg/kg/day.\nHypothyroidism is permanent\n\u0002\nTHYROIDECTOMY\nfor patients who do not wish to\ndo the radioactive drink, compressive goiter, and\nfor those with severe Graves\u2019 eye disease\nTREATMENT ISSUES\nPROPHYLTHIOURACIL (PTU) MECHANISM\ninhi\nbits thyroid hormone synthesis and peripheral con\nversion of T4 to T3 (T3 is more active form). Hold PTU\nfor 4 days prior to radioiodine ablation\nSPECIFIC ENTITIES\nAPATHETIC HYPERTHYROIDISM\nin the elderly,\nlack of signs and symptoms of thyrotoxicosis despite\nbiochemical evidence\nTHYROIDITIS\nsubacute\nthyroiditis\nis\npainful\nwhereas silent thyroiditis is painless. Thyroiditis typi\ncally leads to hyperthyroidism initially as the thyroid\ncells lyse, then a period of hypothyroidism before\nrecovering to euthyroid state\nRelated Topic\nHyperthyroidism in Pregnancy (p. 414)\nSolitary Thyroid Nodule\nNEJM 2004 351:17\nDIFFERENTIAL DIAGNOSIS\nBENIGN (95%)\ncolloid nodule, cyst, thyroiditis,\nbenign follicular neoplasm\nMALIGNANT (5%)\nthyroid carcinoma (papillary,\nfollicular, medullary, anaplastic)\nCLINICAL FEATURES\nRISK FACTORS FOR THYROID CANCER\n\u0002\nHIGH RISK\nfamily history of medullar thyroid car\ncinoma or MEN, rapid tumor growth, firm or hard\nnodule, fixation of nodule, paralysis of vocal cords,\nregional lymphadenopathy, distant metastases\nCLINICAL FEATURES (CONT\u2019D)\n\u0002\nMODERATE RISK\nage <20 or >70, male, previous\nhead and neck radiation, nodule >4 cm [>1.6 in.]\nin diameter or partially cystic, symptoms of com\npression (dysphagia, dysphonia, hoarseness, dys\npnea, cough)\nINVESTIGATIONS\nBASIC\n\u0002\nLAB TESTS\nTSH\n\u0002\nIMAGING\nU/S guided FNA\nSolitary Thyroid Nodule\n345", "text_length": 3617, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 353/464)", "type": "chunk", "chunk_index": 352, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.734533", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.735275", "status": "complete", "chunks_added": 2}